Exponent (EXPO) EBITDA (2010 - 2026)

Exponent has disclosed EBITDA across 17 years of filings, most recently posting $41.4 million for Q2 2026.

• Quarterly EBITDA fell 6.87% year-over-year to $41.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $116.7 million (down 12.41% YoY) and the FY2026 annual result came in at $119.8 million, changed 0.19% from the prior year.
• EBITDA climbed to $41.4 million in Q2 2026, from $29.1 million in the prior quarter.
• Over five years, EBITDA peaked at $45.3 million in Q3 2022 and troughed at $17.2 million in Q3 2025.
• A 5-year average of $31.3 million and a median of $29.9 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA surged 54.15% — and 2025, when it slumped 51.94%.
• Tracing EXPO's EBITDA over 5 years: stood at $22.0 million in 2022, then decreased by 16.52% to $18.4 million in 2023, then soared by 40.52% to $25.8 million in 2024, then grew by 12.35% to $29.0 million in 2025, then soared by 42.5% to $41.4 million in 2026.
• Business Quant data shows EXPO's EBITDA at $41.4 million in Q2 2026, $29.1 million in Q1 2026, and $29.0 million in Q4 2025.